Tehran (IP) – Head of Iran's Pasteur Institute announced that the Iran-Cuba joint COVID vaccine was in its clinical study's final phase (phase three).

Iran PressIran News: Alireza Biglari stated on Sunday that the initial injection of the joint vaccine of the Pasteur Institute of Iran and the Finlay Institute of Cuba was in the final phase.

He noted that the vaccine had been injected for 24,000 Iranians in seven provinces and eight cities.

Of the 24,000 initial injections of the vaccine, there were no particular concerns about side effects, he pointed.

The vaccine has successfully completed phases one and two of clinical studies in Cuba, and the third phase is being conducted simultaneously in Iran and Cuba.

The third phase of the clinical study of the vaccine is underway with 24,000 volunteers in Iran and 44,000 volunteers in Cuba.


Read More:

2nd phase of Razi Cov-Pars COVID-19 vaccine's clinical trial kicks off

Iran to import 7.5M doses of coronavirus vaccine

'COV-Iran Barekat' vaccine is reassuring